Pigmy MicroRNA: surveillance cops in Therapies kingdom

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• MicroRNAs (miRNAs) are small, conserved non-coding RNAs crucial for gene regulation across animal species.
• Dysregulation of miRNAs is linked to various human diseases, including cardiovascular defects, cancer, and neurological disorders.
• Targeting miRNAs offers a promising therapeutic avenue for treating complex diseases.

Purpose of the Study:

• To update the understanding of designing and synthesizing therapeutic chemicals that control miRNA function.
• To propose in-vivo delivery strategies for miRNA-based therapeutics.
• To review the progress of miRNA modulation as a gene therapy approach.

Main Methods:

• Literature review and synthesis of current research on miRNA therapeutics.
• Analysis of chemical entities like antisense oligonucleotides and small molecules for miRNA inhibition.
• Evaluation ofin-vivo delivery systems and associated challenges.

Main Results:

• The study provides updated insights into the design and synthesis of miRNA-modulating therapeutic agents.
• Various in-vivo delivery strategies are proposed, highlighting challenges in cellular and animal incorporation.
• Current advancements in miRNA modulation for treating human diseases are demonstrated.

Conclusions:

• miRNA-targeting therapeutics represent a viable alternative to traditional gene therapy.
• Effective design and delivery of miRNA modulators are critical for successful therapeutic applications.
• Further research into delivery systems is needed to overcome biological barriers for effective in-vivo use.